Home
About Us
About Boan
Culture
Our History
Our Team
Responsibility
R&D
Technology platform
Boan Product Pipeline
Intellectual Property
Production capacity
Products
News
Careers
People Strategy
Employee Stories
Development
Job Opportunities
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact IR
Contact us
简
/
繁
/
EN
Investors
（02186.HK）
HK$
➚
%
Volume(M)
0thousand
Turnover(HK $)
0thousand
Data as of：
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact IR
Year
2022
2023
2024
2025
Search
14
2025-08
Next Day Disclosure Return
14
2025-08
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
08
2025-08
VOLUNTARY ANNOUNCEMENT DULAGLUTIDE INJECTION (BOYOUPING) APPROVED FOR MARKETING IN CHINA
07
2025-08
PLACING OF NEW SHARES UNDER GENERAL MANDATE
04
2025-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
02
2025-07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
23
2025-06
Articles of Association
23
2025-06
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
17
2025-06
VOLUNTARY ANNOUNCEMENT APPROVAL OBTAINED FOR INITIATING CLINICAL TRIALS FOR BA1302 IN THE U.S.
11
2025-06
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
1
2
3
4
5
Follow me
鲁公网安备37069102000284
ICP备：鲁ICP备2021004064号-1
